UNITY Biotechnology Reports Granting of New Employment Inducement Awards
November 03 2021 - 8:00AM
UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology
company developing therapeutics to slow, halt, or reverse diseases
of aging, today announced that from October 19, 2021, through
November 2, 2021, the Compensation Committee of the Board of
Directors (the “Board”) granted two new employees stock-based
awards covering an aggregate of 190,000 shares of UNITY common
stock, including options to purchase an aggregate of 160,000 shares
of UNITY common stock and one grant consisting of 30,000 restricted
stock units which will vest on the one-year anniversary of the
vesting commencement date. The stock-based awards were granted
pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as
amended, which was approved by the Board in March 2020 to provide
for grants to newly hired employees as a material inducement for
them to commence employment with UNITY in accordance with Nasdaq
Stock Market Rule 5635(c)(4).
About UNITYUNITY is developing a new class of
therapeutics to slow, halt or reverse diseases of aging. UNITY’s
current focus is on creating medicines to selectively eliminate or
modulate senescent cells and thereby provide transformative benefit
in age-related ophthalmologic and neurologic diseases.
More information is available
at www.unitybiotechnology.com or follow us
on Twitter and LinkedIn.
MediaCanale CommunicationsJason
SparkJason.spark@canalecomm.com
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Jul 2024 to Aug 2024
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Aug 2023 to Aug 2024